Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the Netherlands

被引：0
|
作者：
Elise R. A. Pennings
Müjde Durmaz
Otto Visser
Eduardus F. M. Posthuma
Djamila E. Issa
Martine E. D. Chamuleau
Pieternella J. Lugtenburg
Marie José Kersten
Avinash G. Dinmohamed
机构：
[1] Amsterdam UMC location University of Amsterdam,Department of Hematology
[2] Cancer Center Amsterdam,Erasmus School of Health Policy and Management
[3] LYMMCARE (Lymphoma and Myeloma Center Amsterdam),Department of Research and Development
[4] Erasmus University Rotterdam,Department of Registration
[5] Netherlands Comprehensive Cancer Organisation (IKNL),Department of Hematology
[6] Netherlands Comprehensive Cancer Organisation (IKNL),Department of Internal Medicine
[7] Leiden University Medical Center,Department of Internal Medicine
[8] Reinier de Graaf Gasthuis,Department of Hematology
[9] Jeroen Bosch Hospital,Department of Hematology
[10] Amsterdam UMC location Vrije Universiteit Amsterdam,Department of Public Health
[11] Erasmus MC Cancer Institute,undefined
[12] University Medical Center Rotterdam,undefined
[13] Erasmus MC,undefined
[14] University Medical Center Rotterdam,undefined
来源：
Blood Cancer Journal | / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Schuster, Stephen J.
    Bishop, Michael R.
    Tam, Constantine S.
    Waller, Edmund K.
    Borchmann, Peter
    McGuirk, Joseph P.
    Jaeger, Ulrich
    Jaglowski, Samantha
    Andreadis, Charalambos
    Westin, Jason R.
    Fleury, Isabelle
    Bachanova, Veronika
    Foley, S. Ronan
    Ho, P. Joy p
    Mielke, Stephan
    Magenau, John M.
    Holte, Harald
    Pantano, Serafino
    Pacaud, Lida B.
    Awasthi, Rakesh
    Chu, Jufen
    Anak, Ozlem
    Salles, Gilles
    Maziarz, Richard T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (01): : 45 - 56
  • [32] Novel agents in relapsed/refractory diffuse large B-cell lymphoma
    Varma, Gaurav
    Goldstein, Jordan
    Advani, Ranjana H.
    HEMATOLOGICAL ONCOLOGY, 2023, 41 : 92 - 106
  • [33] Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Harris, Leonard Jeff
    Patel, Kruti
    Martin, Michael
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 12
  • [34] Phylogenetic Evolution in Refractory/Relapsed Diffuse Large B-Cell Lymphoma
    Ruminy, Philippe
    Rainville, Vinciane
    Mareschal, Sylvain
    Etancelin, Pascaline
    Joly, Berangere
    Picquenot, Jean-Michel
    Bastard, Christian
    Tilly, Herve
    Jardin, Fabrice
    BLOOD, 2012, 120 (21)
  • [35] Relapsed or Refractory Diffuse Large B-Cell Lymphoma: "Dazed and Confused"
    Kesireddy, Meghana
    Lunning, Matthew A.
    ONCOLOGY-NEW YORK, 2022, 36 (06): : 360 - 369
  • [36] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphoma
    Dietliker, N.
    Kiesel, H.
    Mueller, R.
    Mueller, A. M.
    Manz, M.
    Zenz, T.
    Rosler, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 66 - 67
  • [37] Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Sehn, Laurie H.
    Herrera, Alex F.
    Flowers, Christopher R.
    Kamdar, Manali K.
    McMillan, Andrew
    Hertzberg, Mark
    Assouline, Sarit
    Kim, Tae Min
    Kim, Won Seog
    Ozcan, Muhit
    Hirata, Jamie
    Penuel, Elicia
    Paulson, Joseph N.
    Cheng, Ji
    Ku, Grace
    Matasar, Matthew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) : 155 - +
  • [38] Bendamustine/rituximab in relapsed or refractory diffuse large B-cell lymphoma
    Vacirca, J. L.
    Acs, P. I.
    Shimkus, B. J.
    Rosen, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] A prognostic nomogram constructed for relapsed or refractory diffuse large B-cell lymphoma patients
    Jiang, Shiyu
    Qin, Yan
    Liu, Peng
    Yang, Jianliang
    Yang, Sheng
    He, Xiaohui
    Zhou, Shengyu
    Gui, Lin
    Zhang, Changgong
    Zhou, Liqiang
    Sun, Yan
    Shi, Yuankai
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (02) : E11 - E16
  • [40] DeVIC chemotherapy is effective for patients with refractory or relapsed diffuse large B-cell lymphoma
    Okada, Kazuya
    Sakai, Kazuya
    Muranushi, Hiroyuki
    Okamoto, Yusuke
    Sugiura, Hiroyuki
    Sato, Aki
    Sato, Takayuki
    Maeda, Takeshi
    Onishi, Tatsuhito
    Ueda, Yasunori
    ANNALS OF ONCOLOGY, 2015, 26 : 108 - 108
12345